Grant: p38 MAPK in human lung cancers and its potential involvement in treatment resistance to tyrosine kinase inhibitors

  • Basic View
  • XML View
Project Title
p38 MAPK in human lung cancers and its potential involvement in treatment resistance to tyrosine kinase inhibitors
 
Principal Investigator Wong, Maria Pik (Principal investigator)
Co-Investigator(s) Dr Cai Kexia (Co-Investigator)
Professor Han Jiahuai (Co-principal investigator)
Dr Leung Elaine Lai Han (Co-Investigator)
Project Code
N_HKU 754/10
 
Funding Year
2010/2011
 
Amount
500000
 
Panel Medicine
Start Date
01-01-2011
 
Expected Completion
31-12-2012
 
Status
On-going
 
Keywords p38 MAPK, lung cancers, EGFR, Tyrosine Kinase Inhibitor resistance, Epithelial to mesenchymal transition (EMT)
Sponsor NSFC/RGC Joint Research Scheme
Grant Type/Funding Scheme NSFC/RGC Joint Research Scheme
Duration
24
 
[Coming Soon]